Study of Epigenetic and Inflammatory Markers of Accelerated Biological Ageing in the Follow up of Patients With Hodgkin's Lymphoma

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 3, 2022

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Hodgkin Lymphoma in Remission
Interventions
OTHER

peripheral blood sampling

"It is a monocentric and exploratory study, experimental on human tissues in vitro and similar projects do not exist in the literature. This study involves the analysis of peripheral blood in patients with hodgkin lymphoma with the following characteristics:~* in complete remission for at least two years after first-line therapy with stage II b, III or IV at onset (Ann Arbor classification).~* newly diagnosed (stage II b, III or IV, Ann Arbor Classification)."

Trial Locations (1)

40138

RECRUITING

IRCCS Azienda Ospedaliero - Universitaria di Bologna, Bologna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER